OIS@ASCRS

WaveTec Vision Systems

By Tom Salemi | April 24, 2014

WaveTec Vision® Systems, Inc. is a privately-held ophthalmic medical device company and is the proven leader in intraoperative wavefront technology. The company is focused on…

Read More

pSivida

By Tom Salemi | April 24, 2014

Paul Ashton talks about the innovation within pSivida and its early stage work on proteins. pSivida has developed 3 of the 4 sustained delivery systems…

Read More

PowerVision

By Tom Salemi | April 24, 2014

Barry Cheskin discusses PowerVision’s six month data on their pilot study and the beginning their CE mark study. Presenter: Barry Cheskin Barry Cheskin is Co-Founder,…

Read More

Panoptes Pharma

By Tom Salemi | April 24, 2014

Franz Obermayr gives a short overview of Panoptes Pharma founded only last year, covering only one of their developments: C0C01 for local treatment in ophthalmology. Presenter:…

Read More

Ocular Therapeutix

By Tom Salemi | April 24, 2014

Amar Sawhney gives us an update on what’s going on in Ocular Therapeutix, showing us an in depth look at their product pipeline and what…

Read More

EyeSonix

By Tom Salemi | April 24, 2014

Donald Schwartz talks about TUG, which is the only ultrasound treatment designed for all open angle glaucoma. Presenter: Donald Schwartz Donald Schwartz is a comprehensive…

Read More

ClarVista Medical

By Tom Salemi | April 24, 2014

Paul McLean updates us on the progress of the HARMONI™ Modular IOL and its first-in-human clinical study. Presenter: Paul McLean Paul McLean is President and…

Read More

Clarity Medical Systems

By Tom Salemi | April 24, 2014

Keith Mullowney presents Clarity’s multi-product business strategy introducing the products: RetCam & HOLOS™. Presenter: Keith Mullowney Keith L. Mullowney joined Clarity in 2005 as the…

Read More

Anew Optics

By Tom Salemi | April 24, 2014

Anna Hayes describes Anew Optics lens design program with the specific objective of removing or managing significantly post-cataract surgery patient health issues including instability of…

Read More

Industry Perspectives on Ophthalmic Opportunities

By Tom Salemi | April 24, 2014

Gain insight on how industry thinks about a dry eye opportunity, or a cross-linking opportunity, or a uveitis opportunity. The discussion is about no so…

Read More

The Role of OUS Clinical Studies

By Tom Salemi | April 24, 2014

Malvina B. Eydelman, MD give her presentation on some of the newest directions coming out of the FDA for device studies in the US followed…

Read More

Avedro

By Tom Salemi | April 24, 2014

Presenter: David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.